Survivin, the promising target in hepatocellular carcinoma gene therapy.
Liu
Jie
J
State Key Laboratory of Cancer Biology and Institute of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, P. R. China. Jieliu@fmmu.edu.cn
Du
Wenqi
W
Fan
Daiming
D
D017209:Apoptosis; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D015316:Genetic Therapy; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins; D008113:Liver Neoplasms / Q000628:therapy*; D008869:Microtubule-Associated Proteins / Q000235:genetics*; D009363:Neoplasm Proteins / Q000235:genetics*; D017354:Point Mutation; D000077022:Survivin
C107489:BIRC5 protein, human; D051034:Inhibitor of Apoptosis Proteins; D008869:Microtubule-Associated Proteins; D009363:Neoplasm Proteins; D000077022:Survivin